首页> 外文期刊>Expert opinion on therapeutic targets >Targeting the thyrotropin receptor in thyroid disease
【24h】

Targeting the thyrotropin receptor in thyroid disease

机译:针对甲状腺疾病中的促甲状腺激素受体

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: The thyrotropin receptor (TSHR) is essential for thyroid growth and for the production of thyroid hormones. It is unique among the glycoprotein hormone receptors, in that some of the TSHRs undergo cleavage and shedding of the alpha subunit. Areas covered: This review discusses the structure and function of the TSHR, followed by an evaluation of its role in thyroid disease. Possible limitations of the TSHR as a therapeutic target are also discussed. Expert opinion: The TSHR is involved in a number of hereditary and acquired disorders of the thyroid making it of potential importance as a therapeutic target in thyroid disease. Expression of the TSHR in several non-thyroidal tissues and the development of systemic manifestations of thyroid disease suggest that the TSHR is also of interest as a therapeutic target outside the thyroid.
机译:简介:促甲状腺激素受体(TSHR)对于甲状腺生长和甲状腺激素的产生至关重要。它在糖蛋白激素受体中是独特的,因为某些TSHRs经历了α亚基的裂解和脱落。涵盖的领域:这篇综述讨论了TSHR的结构和功能,然后对其在甲状腺疾病中的作用进行了评估。还讨论了TSHR作为治疗靶标的可能局限性。专家意见:TSHR参与了许多遗传性和后天性甲状腺疾病,使其作为甲状腺疾病的治疗靶标具有潜在的重要性。 TSHR在几种非甲状腺组织中的表达以及甲状腺疾病的全身表现的发展表明,TSHR也作为甲状腺以外的治疗靶标而受到关注。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号